Evaluation Study of SPOTme® Skin Cancer Screenings

NACompletedINTERVENTIONAL

Enrollment

431

Participants

Timeline

Start Date

December 1, 2017

Primary Completion Date

October 1, 2018

Study Completion Date

June 1, 2019

Conditions

Skin Cancer

Interventions

BEHAVIORAL

Intervention Arm

Individuals randomized to the intervention group will receive skin cancer screening educational materials.

OTHER

AAD SPOTmeⓇ skin cancer screening

All study participants will have participated in the AAD SPOTmeⓇ skin cancer screening program in either 2016 or 2017.

Trial Locations (1)

Harvard TH Chan School of Public Health, Boston

All Listed Sponsors

collaborator

American Academy of Dermatology (AAD)

UNKNOWN

lead

Harvard School of Public Health (HSPH)

OTHER

NCT03564769 - Evaluation Study of SPOTme® Skin Cancer Screenings | Biotech Hunter | Biotech Hunter